Insulet Corp (PODD.OQ)
Latest Key Developments (Source: Significant Developments)
Jan 9 (Reuters) - ASCENSIA DIABETES CARE::ASCENSIA DIABETES CARE EXPANDS STRATEGIC ALLIANCE WITH INSULET CORPORATION BY SIGNING COMMERCIAL AGREEMENT.ASCENSIA DIABETES CARE - RECIPIENTS OF OMNIPOD DASH WILL RECEIVE CONTOURNEXT ONE METER, CONTOUR NEXT TEST STRIPS PACKAGED WITH INSULIN PUMP.ASCENSIA DIABETES CARE - UNDER TERMS OF NON-EXCLUSIVE COMMERCIAL AGREEMENT, INSULET WILL DISTRIBUTE CONTOUR NEXT ONE BGMS WITH OMNIPOD DASH. Full Article
Nov 8 (Reuters) - Insulet Corp
Nov 6 (Reuters) - Insulet Corp
Nov 2 (Reuters) - Insulet Corp
Insulet Corp:For FY 2016, the Company is reaffirming its revenue guidance of $330 to $350 million.For Q2 2016, the Company is introducing revenue guidance in the range of $81 to $84 million. Full Article
ZURICH, March 7 Swiss insulin pump maker Ypsomed , responding to a report on Wednesday that had sent its shares tumbling, said 2019/20 profit will likely fall amid market uncertainties but will then rebound as it expands with new subsidiaries.